Biome Cholecare 30 caps

Formulated with a clinically-trialled combination of probiotic strains. This formulation has been the subject of a number of randomised, double-blind, controlled trials. One-a-day vege capsules are packaged in pharmaceutical-grade blister packaging for optimal shelf-stability. Clinical evidence to support probiotic strains used: Across a number of human studies, taking a combination of Lactobacillus plantarum KABP™ 011, Lactobacillus plantarum KABP™ 012, and Lactobacillus plantarum KABP™ 013 at 0.4 billion live bacteria each once a day for 12 weeks with no other cholesterol-lowering medications has been found to significantly reduce:

low density lipoprotein cholesterol by up to 20%

total cholesterol by up to 19%

triglycerides by 16% compared to baseline (p<0.001)
while also increasing high-density lipoprotein cholesterol by up to 8%
It has also been found to significantly lower the number of small dense LDL particles (p=0.019), oxidised LDL particles (p<0.05) and total apolipoprotein B-containing particles (p=0.0001)- all factors associated with an increased risk of atherosclerosis. In one observational study, this same combination of probiotic strains was administered in combination with existing statin therapy and was found to reduce LDL cholesterol by a further 25% (p<0.001)

Mechanisms 

Reducing the reabsorption of cholesterol from bile salts via the production of bile salt hydrolase enzymes.
Enhancing the excretion of cholesterol